NCT04397757View on ClinicalTrials.gov

COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

February 6, 2021

Study Completion Date

March 8, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

COVID-19 Convalescent Plasma

2 units of COVID-19 convalescent plasma compatible with their blood type

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04397757 - COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. | Biotech Hunter | Biotech Hunter